We could not find any results for:
Make sure your spelling is correct or try broadening your search.
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing...
NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of...
NEW YORK, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.71 | -30.6034482759 | 2.32 | 2.532 | 1.5 | 54922 | 1.6892022 | CS |
4 | -2.39 | -59.75 | 4 | 4.01 | 1.5 | 69750 | 2.40233861 | CS |
12 | -2.39 | -59.75 | 4 | 4.01 | 1.5 | 69750 | 2.40233861 | CS |
26 | -2.39 | -59.75 | 4 | 4.01 | 1.5 | 69750 | 2.40233861 | CS |
52 | -2.39 | -59.75 | 4 | 4.01 | 1.5 | 69750 | 2.40233861 | CS |
156 | -2.39 | -59.75 | 4 | 4.01 | 1.5 | 69750 | 2.40233861 | CS |
260 | -2.39 | -59.75 | 4 | 4.01 | 1.5 | 69750 | 2.40233861 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions